DrugDashboards

Acetylcysteine

acetylcysteine · ACETYLCYSTEINE 200 mg/mL · Injection, Solution · Intravenous · Sagent Pharmaceuticals

NDC 25021-0812-30 · 4 VIAL in 1 CARTON / 30 mL in 1 VIAL · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.3890per billing unit (100 MG)HCPCS J0132 · Jul 1, 2026
  • Part D plans paid (avg)$0.9436per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$200.00
Reported to Texas DSHS · 2026 annual filing · Sagent Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 100 MG
$0.389
HCPCS J0132 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$9,781
47 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $92.69 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA091684
TE code
AP
Approval date
Oct 31, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of acetylcysteine (Injection, Solution)

LabelerStrengthFirst seenLast seen
Sagent PharmaceuticalsACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 3, 2026
Cumberland Pharmaceuticals Inc.ACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCACETYLCYSTEINE 6 g/30mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 2, 2026
Onesource Specialty Pharma LimitedACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCACETYLCYSTEINE 200 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCACETYLCYSTEINE 200 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Acetylcysteine — NDC 25021-0812-30," retrieved September 3, 2026, https://drugdashboards.com/drug/25021081230.

Free to cite with attribution — see how the data is put together.